Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-09, Stock:LLY, The news for the past five days is as follows:
2020-06-02: NEWS1: Coronavirus latest: Tuesday, June 2.NEWS2: These 2 charts show why record-high stock valuations shouldn’t worry investors.NEWS3: Lilly Begins Coronavirus Study to Evaluate Antibody Therapy.NEWS4: Coronavirus Treatment Search Still on, Lilly, Gilead Give Updates.NEWS5: AstraZeneca Ranked Most Inventive, Roche Most Innovative.NEWS6: Morning Bell With Jim Cramer: Buy Regeneron.NEWS7: NextGen (NXGN) Earnings and Revenues Beat Estimates in Q4.NEWS8: Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive.NEWS9: Don’t Only Bet on Fast Vaccines, Root for Covid Treatments.NEWS10: Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions.
2020-06-03: NEWS1: How Are Biotech ETFs Reacting to Coronavirus Treatment News?.NEWS2: Wednesday Morning Market Highlights.NEWS3: Bristol Myers' Zeposia Meet Goals in Ulcerative Colitis Study.NEWS4: Why These 5 Pharma Stocks Are Outplaying 90% Of The Stock Market.NEWS5: HealthEquity (HQY) Q1 Earnings and Revenues Miss Estimates.NEWS6: EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus.NEWS7: EULAR 2020: Lilly's Taltz® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis.NEWS8: Eli Lilly Leaps Past Regeneron's COVID-19 Treatment Candidate.
2020-06-04: NEWS1: Roche's COVID-19 Test Gets FDA's Emergency Use Authorization.NEWS2: Change Healthcare (CHNG) Q4 Earnings, Revenues Top Estimates.
2020-06-05: NEWS1: Antibody Drugs Could Help Curb the Pandemic. What Investors Need to Know..NEWS2: Cooper Companies (COO) Misses on Q2 Earnings and Revenues.NEWS3: Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals.
2020-06-08: NEWS1: Eli Lilly (LLY) Flat As Market Gains: What You Should Know.NEWS2: Coronavirus update: Global death tally tops 400,000; health experts urge police to stop using tear gas on anti-racism protesters.NEWS3: Eli Lilly Kicks Off a Clinical Trial for a Second COVID-19 Antibody Treatment.NEWS4: Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication.NEWS5: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS6: Lilly to Participate in Goldman Sachs Global Healthcare Conference.NEWS7: Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment.NEWS8: Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial.

Answer: Decrease